Fig. 4From: Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033)Predicted differences in quality-adjusted survival benefit by age, ER status, and primary breast cancer stage in women with no family history of breast cancer. Quality-adjusted survival benefit of CPM in women with no family history of breast cancer in relation to age, ER status, and primary breast cancer stage. ER estrogen receptor, QALY quality-adjusted life yearBack to article page